AKOS B033687
|
- $45 - $796.95
- Product name: AKOS B033687
- CAS: 849807-02-9
- MF: C14H14FNO
- MW: 231.27
- EINECS:
- MDL Number:MFCD07391198
- Synonyms:AKOS B033687;4-(4-Fluoro-benzyloxy)-benzylamine;(4-((4-fluorobenzyl)oxy)phenyl)methanamine;[4-[(4-fluorophenyl)methoxy]phenyl]methanamine;Benzenemethanamine, 4-[(4-fluorophenyl)methoxy]-
11 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 100mg
- 500.00mg
- 500MG
- 1g
- 1.00g
- 5g
- ManufacturerAK Scientific
- Product number0626AF
- Product description4-(4-Fluoro-benzyloxy)-benzylamine
- Packaging1g
- Price$342
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0070174
- Product description4-(4-FLUORO-BENZYLOXY)-BENZYLAMINE 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12025096
- Product description(4-((4-Fluorobenzyl)oxy)phenyl)methanamine 95+%
- Packaging5g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12025096
- Product description(4-((4-Fluorobenzyl)oxy)phenyl)methanamine 95+%
- Packaging5g
- Price$752
- Updated2026-05-27
- Buy
- ManufacturerMatrix Scientific
- Product number032743
- Product description4-(4-Fluoro-benzyloxy)-benzylamine
- Packaging500mg
- Price$141
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number032743
- Product description4-(4-Fluoro-benzyloxy)-benzylamine
- Packaging500.00mg
- Price$141
- Updated2026-05-18
- Buy
- ManufacturerMatrix Scientific
- Product number032743
- Product description4-(4-Fluoro-benzyloxy)-benzylamine
- Packaging1g
- Price$217
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number032743
- Product description4-(4-Fluoro-benzyloxy)-benzylamine
- Packaging1.00g
- Price$217
- Updated2026-05-18
- Buy
- ManufacturerTRC
- Product numberF702950
- Product description{4-[(4-Fluorobenzyl)oxy]benzyl}amine
- Packaging500mg
- Price$285
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberF702950
- Product description{4-[(4-Fluorobenzyl)oxy]benzyl}amine
- Packaging50mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberF702950
- Product description{4-[(4-Fluorobenzyl)oxy]benzyl}amine
- Packaging100mg
- Price$65
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0626AF | 4-(4-Fluoro-benzyloxy)-benzylamine | 1g | $342 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0070174 | 4-(4-FLUORO-BENZYLOXY)-BENZYLAMINE 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
| Crysdot | CD12025096 | (4-((4-Fluorobenzyl)oxy)phenyl)methanamine 95+% | 5g | $752 | 2021-12-16 | Buy |
| Crysdot | CD12025096 | (4-((4-Fluorobenzyl)oxy)phenyl)methanamine 95+% | 5g | $752 | 2026-05-27 | Buy |
| Matrix Scientific | 032743 | 4-(4-Fluoro-benzyloxy)-benzylamine | 500mg | $141 | 2021-12-16 | Buy |
| Matrix Scientific | 032743 | 4-(4-Fluoro-benzyloxy)-benzylamine | 500.00mg | $141 | 2026-05-18 | Buy |
| Matrix Scientific | 032743 | 4-(4-Fluoro-benzyloxy)-benzylamine | 1g | $217 | 2021-12-16 | Buy |
| Matrix Scientific | 032743 | 4-(4-Fluoro-benzyloxy)-benzylamine | 1.00g | $217 | 2026-05-18 | Buy |
| TRC | F702950 | {4-[(4-Fluorobenzyl)oxy]benzyl}amine | 500mg | $285 | 2021-12-16 | Buy |
| TRC | F702950 | {4-[(4-Fluorobenzyl)oxy]benzyl}amine | 50mg | $45 | 2021-12-16 | Buy |
| TRC | F702950 | {4-[(4-Fluorobenzyl)oxy]benzyl}amine | 100mg | $65 | 2021-12-16 | Buy |
Properties
Boiling point :362.6±27.0 °C(Predicted)
Density :1.166±0.06 g/cm3(Predicted)
pka :9.25±0.10(Predicted)
Density :1.166±0.06 g/cm3(Predicted)
pka :9.25±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|